MENLO PARK, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis, today announced presentations at the following upcoming investor conferences: TD Cowen’s 45th Annual Health Care ConferenceDate: Tuesday, March 4th, 2025Time: 10:30AM ET Leerink Global Healthcare ConferenceDate: Wednesday, March 12th, 2025 ...